Creation of the Cohort of COVID19 patients and samples associated with the Biobank of the Instituto de Investigación Sanitaria Galicia Sur (IISGS)
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:0 publications
Grant number: COV20_00698
Grant search
Key facts
Disease
COVID-19Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
EVA POVEDA LÓPEZResearch Location
SpainLead Research Institution
FUNDACIÓN BIOMÉDICA GALICIA SURResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
N/A
Special Interest Tags
Data Management and Data Sharing
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The creation of the cohort of COVID19 patients and samples associated with the IISGS Biobank in the health area of Vigo is the basis for the study of the COVID19 disease in a standardized and quality way. It will allow the execution of clinical and experimental studies to increase our knowledge and optimize the prevention, diagnosis, clinical follow-up and treatment of patients infected by SARS-COV-2 at a local and global level, favoring consortia and study groups with other national centers and international organizations for the development of joint research projects. To this end, a Coordination Unit of the COVID19-IISGS Cohort and a Scientific-Technical Committee have been created for the evaluation of research projects that require the use of data and samples from the cohort once they have the approval of the Relevant Ethics Committees.